$0.0002
+0 (+0%)
At Close: Jun 03, 2026
DexCom: A Superior Business Model But Watch Out For Debt Level (NASDAQ:DXCM)
03:22pm, Sunday, 20'th Sep 2020
DexCom produces continuous glucose monitoring devices. The stock price has increased steeply in the last one year, but a slight dip recently constitutes an opportunity for investors.
Dexcom Announces First-Ever Registry Dedicated to Tracking Outcomes of In-Hospital Real-Time CGM Use in Response to the COVID-19 Pandemic
12:00am, Wednesday, 16'th Sep 2020
Dexcom announces first-ever registry dedicated to tracking outcomes of in-hospital real-time CGM use in response to the COVID-19 pandemic
Massive container ship - bigger than 4 football fields - sets record under Bayonne Bridge
02:30pm, Sunday, 13'th Sep 2020
Saturday's arrival of the CMA CGM Brazil, a 1,200-foot container ship, is hailed by the Port Authority as an example of why the Bayonne Bridge had to be raised.
E-Commerce Growth Driving Shipping Surge, Investments at France’s CMA CGM
06:45pm, Friday, 11'th Sep 2020
The head of the container line says big clients like Amazon and Walmart want end-to-end logistics solutions from shipping companies.
Tandem announces New England Journal of Medicine publication of pediatric study showing increased time in range with Control-IQ technology.
Nemaura Medical Issues Presentation Pertaining to the use of Continuous Glucose Monitoring in COVID-19 Patients
11:00am, Wednesday, 19'th Aug 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga
Nemaura Medical Reports Results and Provides Business Update for the First Quarter Ended June 30, 2020
10:59am, Monday, 17'th Aug 2020
Nemaura Medical Inc. (NASDAQ: NMRD) ("Nemaura"), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous glucose monitor (CGM), together with BEAT™diabetes,
PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the developmen
Senseonics Holdings, Inc. Reports Second Quarter 2020 Financial Results
12:00am, Monday, 10'th Aug 2020
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantab
Invest Into The Future With ESG: Medtronic Plc (NYSE:MDT)
06:14pm, Friday, 07'th Aug 2020
Medtronic is the world’s leading medical sales devices company with a market cap over $130 billion. This company offers a unique combination of an ESG play and a hedge against election volatility.
Senseonics Announces Positive Coverage Decision for Eversense CGM from Highmark Inc.
12:00am, Friday, 07'th Aug 2020
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implant
LD Micro: Announces Preliminary List of Presenters for the LD-500
05:43pm, Thursday, 06'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
CompuGroup Medical : also well on track in second quarter | MarketScreener
06:15am, Thursday, 06'th Aug 2020Nemaura Announces Correction and Pricing of Public Offering
12:03pm, Tuesday, 28'th Jul 2020
Nemaura Medical Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugar
Sign In
Buy NMRD